The method with the use of MBL-AJ has allowed identifying statistically reliable differences between the levels of lectin-binding CEA between healthy women and patients with cervical cancer, and between patients with benign and malignant neoplasms [13]. This evidence concerns the gene CEACAM5 and cancer.